1VILLARROEL DORREGO M, CORRENTI M, DELGADO R, et al. Orallichen planus: immunohistology of mucosal lesion [ J ]. OralPathol Med, 2002,31 (7) :410 - 412.
2ZHAO ZZ, SAVAGE NW, SUGERMAN PB, et al. Mast cell/ Tcell interactions in oral lichen planus [ J]. Oral Patho! Med, 2002,31 (4) :189 - 191.
3KAWAMURA E, NAKAMURA S, SASAKI M, et al. Accumula- tionof oligoclonal T cells in the infiltrating lymphocytes in oralli- chen planus [ J ]. Oral Pathol Med, 2003,32 (5) :282 - 285.
8VINCENGT SD. Oral lichen planus:the clinical hisrorical and therapeutic features of 100 cases[J]. Oral Surg,1990,70(2) :165.
9SHIN SC, KIM JV, OH I J. Mucoadhesive andphysic, ochemical charact erization of carbopol, poloxamer gels contain, indtriamcin- olone aoetonide[ J ]. Drug Dev Ind pharm,2000,26:307.
10SUWIPA U, YOSHIE M. Invit ro permeation studies of triamcinolon eacetonide mouthmashex [ J]. International Journal of Pharmao- ceut ics,2001,220 : 111.
3Srinivasan M, Jewell SD. Quantitative estimation of PCNA, c-myc,EGFR and TGF-alpha in oral submueous fibrosis- an immunohistochemical study. Oral Oncol, 2001, 37:461-467.
4Silverman S Jr. Oral lichen planus: a potentially premalignant lesion. J Oral Maxillofac Surg, 2000, 58:1286-1288.
5Bankfalvi A, Krassort M, Vegh A, et al. Deranged expression of the E-cadherin/beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas. J Oral Pathol Med, 2002, 31:450-457.
6Guo RF, Lentsch AB, Sarma JV, et al. Activator protein-1 activation in acute lung injury. Am J Pathol, 2002, 161 : 275-282.
7de Sousa SO, Mesquita RA, Pinto DS Jr, et al. Immunolocalization of c-Fos and c-Jun in human oral mucosa and in oral squamous cell carcinoma. J Oral Pathol Med, 2002, 31:78-81.
